Governance
Foundation Board
Alain Robert, President of the Foundation Board
- since 1997 - 2022 in leading positions with the Union Bank in Switzerland (UBS) and UBS AG
- former Vice Chairman of Global Wealth Management of UBS Switzerland AG
- former Member of the UBS Group
- former Head of UBS Wealth Management and Business Banking Switzerland
- holds various council mandates in business and culture in Switzerland
Prof. Rudolf Aebersold, Member of the Foundation Board
- is a cell biologist and devotes himself to the investigation of proteins
- he has studied at the University of Basel and at the California Institute of Technology
- he was professor at the University of British Colombia in Vancouver and at the University of Washington in Seattle
- he was one of the co-founders of the Institute of System Biology in Seattle
- since 2004 Prof. Aebersold is professor of System Biology at the Institute of Molecular System Biology at the ETH Zurich and at the Scientific Faculty of the University of Zurich
- since February 2020 Prof. Aebersold is professor emeritus of System Biology at the Institute of Molecular System Biology at the ETH Zurich and at the Scientific Faculty of the University of Zurich
Riccardo Braglia, Member of the Foundation Board
- Executive Chairman of the Helsinn Group, a family-run global biopharma company with a leading position in cancer supportive care and a focus on cancer therapeutics.
- Venture capitalist: Chairman and General Partner of 3B Future Health Funds. Board member of HAS Healthcare Advanced Synthesis SA a pharma chemical CDMO.
- Philanthropist: Co-founder and Chairman of Fondazione Nuovo Fiore, a foundation that promotes, encourages and supports basic education for young people in sub Sahara countries on the African continent and in particular in Ethiopia, member of the board of Fondazione Gabriele and Anna Braglia
- Member of various boards in the fields of business and culture in Switzerland and abroad
Dr. Heimo Scheuch, Member of the Foundation Board
- since 2009 CEO of Wienberger AG, a leading international group provider of innovative building material and infrastructure headquartered in Vienna
- studied law, economics and business administration in Vienna and Paris and holds a doctorate in law
- Chairman of the Supervisory Board of Wiener Börse AG and holds various mandates in business and culture in Austria, Belgium and Germany
Foundation Advisory Board
Avv. Francesco Galli (legal advisor)
- Law degree in St. Gallen and Zurich
- Lawyer and notary patent in the canton of Ticino
- Partner in a renowned law firm in Lugano
Prof. Dr Markus G. Manz (scientific advisor)
- Professor of Haematology at the Medical Faculty of the University of Zurich since 2009 and Director of the Department of Medical Oncology and Haematology at the University Hospital Zurich. He also heads the Leukaemia, Lymphoma and Myeloma Centre of the Comprehensive Cancer Center Zurich.
- He studied human medicine at the University of Tübingen in Germany, where he also obtained his doctorate and completed his further medical training as an internist.
Office
Corina Albertini, Managing Director
Dr. Vanessa Johnen, Scientific Director
Valeria Zanon, Operations & Special Projects
Renate Cadra, Secretary
INNOVATION AND SUSTAINABILITY
The Helmut Horten Foundation has been supporting the Institute for Research in Biomedicine in Bellinzona since 1999 and the Department of Biology at the ETH Zurich since 2009. These are innovative and sustainable institutions working for the further development of research in the field of human immunology. Thanks to the support of the Helmut Horten Foundation, they are now in a position to significantly strengthen their leading international standing in the fields of life sciences and personalised medicine.